Clinical trial Recruiting at 1 site Interventional Ages 18 to 100

Effects of nasal high flow on exercise tolerance in COPD patients

Official title: Physiologic Effects of Nasal High Flow on Exercise Tolerance in Chronic Obstructive Pulmonary Disease (COPD)

Run by University of Miami · NCT06578156 · Data updated 2026-11-12

This study is testing if using a high flow nasal oxygen therapy can help people with COPD walk longer and feel less short of breath during exercise compared to regular low flow oxygen.

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment45 (estimated)
SponsorUniversity of Miami
Academic / other
Locations1 site (Miami, Florida)
StatusRecruiting
StartedDecember 12, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJune 22, 2026
Trial IDNCT06578156 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older diagnosed with COPD who can walk independently and use low-flow oxygen.

Probably not a fit

Patients who are pregnant, on bedrest, or require high-flow oxygen or non-invasive ventilation during the day may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of nasal high flow (NHF) therapy at 70 liters per minute on exercise tolerance in patients with Chronic Obstructive Pulmonary Disease (COPD) using a 6-Minute Walk Test (6-MWT). It aims to determine the relationship between self-reported dyspnea and the use of NHF compared to low flow nasal cannula during exercise. The study will involve COPD patients who can ambulate independently and are currently using low-flow oxygen or none at all. Participants will be monitored for their exercise performance and breathing difficulties during the test.

Why it matters

Potential benefit: If successful, this study could improve exercise tolerance and quality of life for COPD patients by optimizing oxygen delivery during physical activity.

How similar studies have gone: Other studies have shown promising results with nasal high flow therapy in respiratory conditions, suggesting potential benefits in similar approaches.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Able to consent
* Age 18 years or older
* Diagnosis of COPD
* Ability to ambulate without assistance
* Use of low-flow nasal cannula ≤ 4 L/min or no supplemental oxygen (O2) at all

Exclusion Criteria:

* Pregnancy
* Being on bedrest
* Inability to consent or cooperate with the study
* Using of \> 4 L/min of supplemental O2 or requiring non-invasive ventilation during the daytime
* Hemodynamic instability (resting heart rate \> 130/minute, systolic blood pressure of ≤ 90 mmHg or ≥ 180 mmHg)
* Metal implants in the thoracic regions (pacemakers, Automatic Implantable Cardioverter Defibrillator (AICD), plates, screws, rods, and disc replacements)

Where it's running

  • University of Miami
    Miami, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

    This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

    Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

  • Cognitive load and inhaler technique in COPD

    This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.

    Recruiting Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara · Timișoara, Timiș County · NCT07786220

  • Balance training after pulmonary rehab for COPD to help steadiness and reduce falls

    A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.

    Recruiting at 3 sites Teesside University · Middlesbrough and 2 other locations · NCT07750821

  • Continuous vs High-Intensity Interval Exercise in COPD

    This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.

    Recruiting George Papanicolaou Hospital · Thessaloniki, Exohi · NCT07707271

  • Biomarker clues for COPD, IPF, and lung cancer

    This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.

    Recruiting Fondazione Don Carlo Gnocchi ETS · Milan, Milan · NCT07707245

  • HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults

    This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.

    Recruiting Phase 2 Guangdong Hengrui Pharmaceutical Co., Ltd · Shanghai, Shanghai Municipality · NCT07640451

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.